Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin Effects on Renal Endothelial Function in Hypercholesterolemia
NCT00160745Phase 2Completed
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypercholesterolemia comparing Rosuvastatin with Placebo (2 arms). Primary endpoint: Change in renal plasma flow from baseline in response to L-NMMA infusion at 6 weeks. Status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00160745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160745.